Latest stock market podcasts

From the helm: Mesoblast (ASX:MSB), Director, Silviu Itescu

Bell Direct
March 20, 2026

In this episode of From the Helm, Grady sits down with Mesoblast Director Silviu Itescu, to unpack the recent approval and launch of their Ryoncil drug for children, their outlook for the next 12 months in capturing the adult market, and their extensive pipeline of further products.

Weekly Wrap 5 June

Bell Direct
June 5, 2026

Weekly Wrap 22 May

Bell Direct
May 22, 2026

Weekly Wrap 15 May

Bell Direct
May 15, 2026

Weekly Wrap 8 May

Bell Direct
May 8, 2026

Weekly Wrap 1 May

Bell Direct
May 1, 2026

Weekly Wrap 24 April

Bell Direct
April 24, 2026

Weekly Wrap 17 April

Bell Direct
April 17, 2026